Barnes, T. R., Leeson, V. C., Paton, C., Marston, L., Davies, L., Whittaker, W., . . . Amos, T. (2017). Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): A double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness. Health Technol Assess.
Citação norma ChicagoBarnes, Thomas Re, et al. "Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia (AMICUS): A Double-blind, Placebo-controlled, Randomised Trial of Clinical Effectiveness and Cost-effectiveness." Health Technol Assess 2017.
Citação norma MLABarnes, Thomas Re, et al. "Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia (AMICUS): A Double-blind, Placebo-controlled, Randomised Trial of Clinical Effectiveness and Cost-effectiveness." Health Technol Assess 2017.